A Project to Study Probiotic Beauty Products on Skin Improvement

Chia Nan University of Pharmacy & Science

The aim of the study was to use probiotic beauty products for 4 weeks and evaluate the impact of products on healthy skin.

Study Overview

Detailed Description

Twenty subjects were recruited and informed to apply the lotion gel twice per day (3~5 mg/cm2 once) for 4 weeks. Two kinds of facial lotiongels, "A" gel and "B" gel, were provided to every subject. The "A" gel (TAC/Collagen lotiongel) was applied on subjects' right face and the "B" gel (placebo lotion) on their left face (formula showed as Table S2). Ordinary cosmetics usage was permitted but any change of usage was not allowed during the intervention. Outdoor activities (sun exposure) and the usage of sunscreen lotion were not limited in this study. Every subject was required to inspect his/her skin condition on week 0 and 4. Before inspection, the face was washed with water and waited for 30 min in an air-conditioned room (25°C, humility 55 ± 5%). Among these 20 subjects, eight of them had severe acne with at least two acne lesions on each side of face when participating this trial. They were instructed for more visits to evaluate the symptom of acne on week 1 and 2.

Skin hydration (Corneometer CM825, Courage + Khazaka Electroni, Germany), sebum (Callegari 1930, Italy), and inflammation detection (Chroma Meter MM-500, Minolta, Japan) of upper cheek were measured in every subject. The improvement in inflammation was positively correlated with a decrease of a* value or an increase of L* value. VISIA® Complexion Analysis (VISIA® Complexion Analysis, U.S.A.) was also employed to measure the skin inflammation, porphyrins numbers and brown spot numbers of whole face. The result was presented as the mean value and the relative percentage (%) to the baseline.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tainan, Taiwan, 71710
        • Chia Nan University of Pharmacy & Science

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

Healthy volunteers aged above 20 years old

Exclusion Criteria:

  1. Subject with diseases of the skin, heart, liver, kidney, endocrine and other organs and patients with mental illness (according to medical history).
  2. Subjects who have known cosmetic, drug or food allergies, difficulty in digestive tract absorption or disorder.
  3. Female who is pregnant or nursing or planning to become pregnant during the course of the study.
  4. Received facial laser therapy, chemical peeling or UV overexposure in the past 4 weeks.
  5. Involuntary subject
  6. People who is taking chronic disease medication

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: "A" gel (TAC/Collagen gel)
The "A" gel (TAC/Collagen gel) was applied on subjects' right face
Apply it twice per day for 4 weeks
Placebo Comparator: "B" gel (placebo lotion)
the "B" gel (placebo lotion) on their left face
Apply it twice per day for 4 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effects of the TAC/Collagen Gel on Human Skin Hydration
Time Frame: Subjects will be tested in the 4th week
Corneometer® CM825 was utilized to measure skin moisture. Units: arbitrary Corneometer® units 0-120
Subjects will be tested in the 4th week
Effects of the TAC/Collagen Gel on Human Skin Sebum
Time Frame: Subjects will be tested in the 4th week
Callegari 1930 was utilized to measure skin inflammation. Units: arbitrary units.
Subjects will be tested in the 4th week
Effects of the TAC/Collagen gel on Human Skin Inflammation
Time Frame: Subjects will be tested in the 4th week
Chroma Meter MM-500 was utilized to measure skin inflammation. Units: arbitrary units.
Subjects will be tested in the 4th week
Effect of TAC/Collagen Gel on Human Acne Healing and Porphyrins Numbers
Time Frame: Subjects will be tested in the 4th week
VISIA Complexion Analysis System was utilized to measure skin texture. Units: arbitrary units
Subjects will be tested in the 4th week
Effects of the TAC/Collagen Gel on Human Skin Brown Spot Numbers
Time Frame: Subjects will be tested in the 4th week
VISIA Complexion Analysis System was utilized to measure skin texture. Units: arbitrary units
Subjects will be tested in the 4th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Chia-Hua Liang, PhD, Chia Nan University of Pharmacy & Scienc

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 18, 2020

Primary Completion (Actual)

August 1, 2020

Study Completion (Actual)

August 15, 2020

Study Registration Dates

First Submitted

March 3, 2022

First Submitted That Met QC Criteria

March 3, 2022

First Posted (Actual)

March 11, 2022

Study Record Updates

Last Update Posted (Actual)

March 11, 2022

Last Update Submitted That Met QC Criteria

March 3, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TSMHIRB-2-R-025-2.1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Skin Diseases

Clinical Trials on TAC/Collagen gel

3
Subscribe